Pregnancy outcome in inflammatory bowel disease;Pronostic de la grossesse au cours des maladies inflammatories intestiales

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 5, 1999, Pages 464-469

  Tennenbaum, Ruth ^a   Marteau, Philippe ^b   Elefant, Elisabeth ^c   Rambaud, Jean Claude ^b   Modigliani, Robert ^d   Gendre, Jean Pierre ^a   Cosnes, Jacques ^a  

^a HÔPITAL ROTHSCHILD   (France)

^b Hopital Saint Lazare   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Azathioprine; Inflammatory bowel disease; Mesalamine; Pregnancy

Indexed keywords

AZATHIOPRINE; MESALAZINE; OLSALAZINE; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; HUMAN; HYPOTROPHY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PREMATURE LABOR; QUESTIONNAIRE; SPONTANEOUS ABORTION; THERAPEUTIC ABORTION;

EID: 0033030063     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baiocco PJ, Korelitz BI. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984;6:211-6.
2. Nielsen O, Andreasson S, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983;18:735-42.
3. Nielsen O, Andreasson S, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984;19:724-32.
4. Porter RJ, Stirrat GM. The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis. Br J Obstet Gynaecol 1986;93:1124-31.
5. Fedorkow D, Persaud D, Nimrod A. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001.
6. Baird D, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94.
7. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986;27:821-5.
8. Khosla R, Willoughby CP, Jewell DP. Crohn's disease and pregnancy. Gut 1984;25:52-6.
9. Mogadam M, Dobbins WO, Korelitz BI, Ahmed SW. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroïds on fetal outcome. Gastroenterology 1981;80:72-6.
10. Woolfson K, Cohen Z, McLeod RS. Crohn's disease and pregnancy. Dis Colon Rectum 1990;33:869-73.
11. Mulder CJ, Tytgat GN, Weterman IT, Dekker W, Blok P, Schrijver M, et al. Double-blind comparison of slow release 5-amino-salicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988;95:1449-53.
12. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981-7.
13. Ewe K, Press AG, Singe C, Stufler M, Ueberschaer B, Hommel G, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993;105:367-72.
14. Sahmoud T, Mary JY. Mesalazine as maintenance treatment in Crohn's disease: is it the long awaited solution? Gut 1997;40:284-5.
15. Cammà C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-73.
16. Papiernik E. Prévention de la prématurité. In : Papiernik E, Cabrol D, Pons JC. Obstétrique. Paris : Flammarion Médecine Science, 1995:611-31.
17. Goujard J, Gracco de Lay MO, Crost M, Maillard F. Malformations congénitales et pathologie. In : Grandes Enquêtes. Paris : INSERM, Doin, 1984:45-53.
18. Leng JJ, Hocke C. Avortements spontanés. Aspects cliniques, prévention, conduite à tenir. In : Thoulon JM, Puech F, Boog G. Obstétrique. Paris : Ellipses, 1995:241-54.
19. Bortoli A, Tattarella M, Prada A, deFranchis R, Beretta L, Mortara G, et al. Inflammatory bowel disease and pregnancy (abstract). Gastroenterology 1997;112 (suppl):A940.
20. Marteau P, Tennenbaum R, Elefant E, Lemann M, Cosnes J. Fetal outcome in 125 IBD women treated with mesalazine microgranules during pregnancy. Aliment Pharmacol Ther 1998;12:1101-8.
21. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23-8.
22. O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978;2:955-7.
23. Reimers TJ, Sluss PM. 6-mercaptopurine treatment of pregnant mice: effect on second and third generations. Science 1978;201:65-7.
24. Saarikoski S, Seppala M. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973;115:1100-6.
25. Penn I, Makowski EI, Harris P. Parenthood following renal transplantation. Kidney Int 1980;18:221-33.
26. Ramsey-Goldman R, Schilling E. Immunosupressive drug use during pregnancy. Rheum Dis Clin North Am 1997;23:149-67.
27. Roubenoff R, Hoyt J, Petri M, Hochberg MC, Hellmann DB. Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 1988;18:88-110.
28. Leb DE, Weisskopf B, Kanowitz BS. Chromosome aberrations in the child of a kidney transplant recipient. Arch Intern Med 1971;128:441-4.
29. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-6.
30. Francella A, Dayan A, Rubin P, Chapman M, Present D. 6-mercaptopurine is safe therapy for child bearing patients with inflammatory bowel disease: a case control study (abstract). Gastroenterology 1996;110:A 909.
31. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-37.
32. Bouhnik Y, Lémann M, Mary JY, Scemama G, Taï R, Matuchansky C, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;347:215-9.